SCHEMBL7999239

SCHEMBL7999239

CCOc1ccc(C2c3ccccc3Oc3ccccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
LMNA P02545 3/20 0.53
HTT P42858 2/20 0.53
MAPK1 P28482 1/20 0.53
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
USP2 O75604 2/20 0.47
GAA P10253 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NQO1 P15559 1/20 0.45
LTA4H P09960 1/20 0.44
KCNA3 P22001 1/20 0.44
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29612322 0.88 MAPT (0.49) MAPTLMNAHTTMAPK1ALDH1A1
SCHEMBL383949 0.84 KCNA3 (0.52) MAPTLMNAHTTMAPK1GAA
SCHEMBL707761 0.81 MAPT (0.53) MAPTLMNAHTTGAAMEN1
SCHEMBL9698291 0.81 MAOA (0.45) MAPTLMNAHTTMAPK1LTA4H
SCHEMBL28493177 0.80 MEN1 (0.50) MAPTLMNAHTTMAPK1ALDH1A1
SCHEMBL16450352 0.77 CYP3A4 (0.43) MAPTLMNAHTTMAPK1USP2
SCHEMBL10143925 0.77 MAPT (0.63) MAPTLMNAHTTMAPK1ALDH1A1
SCHEMBL7058082 0.75 FFAR4 (0.49) MAPTLMNAHTTGAATDP1
SCHEMBL29562307 0.75 GAA (0.53) MAPTLMNAHTTALDH1A1GAA
SCHEMBL13379253 0.75 CYP3A4 (0.44) MAPTLMNAHTTMAPK1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0886638-A4 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2000-12-27 EP disclosed
EP-0886638-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1998-12-30 EP disclosed
WO-1997019092-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1997-05-29 WO disclosed